SCHEMBL4534782

SCHEMBL4534782

O=C(O)COc1nc(CCNc2ncnc3[nH]cnc23)cc2cccc(Cl)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 5/20 0.38
STK3 Q13188 2/20 0.34
STK4 Q13043 1/20 0.34
LRRK2 Q5S007 1/20 0.34
MAPK1 P28482 2/20 0.33
HTT P42858 2/20 0.33
PIK3CD O00329 1/20 0.33
ABCB11 O95342 1/20 0.33
TBXA2R P21731 1/20 0.33
PIK3R1 P27986 1/20 0.33
HTR2A P28223 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
PDE3A Q14432 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KMT2A Q03164 1/20 0.33
KCNJ5 P48544 1/20 0.33
KCNJ3 P48549 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4537519 0.91 KDM4E (0.34) BTKSTK3STK4LRRK2MAPK1
SCHEMBL4530994 0.86 CYP1A2 (0.37) BTKMAPK1PIK3CDABCB11TBXA2R
SCHEMBL3702416 0.80 PIK3CD (0.42) BTKPIK3CDABCB11TBXA2RPIK3R1
SCHEMBL3702405 0.80 PIK3CD (0.42) BTKPIK3CDABCB11TBXA2RPIK3R1
SCHEMBL4531006 0.77 SGK1 (0.33) PIK3CDABCB11TBXA2RPIK3R1HTR2A
SCHEMBL291170 0.74 HTT (0.34) MAPK1HTTPIK3CDPIK3R1PIK3CA
SCHEMBL935671 0.73 PIK3CD (0.51) PIK3CDABCB11TBXA2RPIK3R1HTR2A
SCHEMBL3701506 0.72 PIK3CD (0.40) PIK3CDABCB11TBXA2RPIK3R1HTR2A
SCHEMBL3701510 0.72 PIK3CD (0.40) PIK3CDABCB11TBXA2RPIK3R1HTR2A
SCHEMBL4572211 0.72 PIK3CD (0.40) PIK3CDABCB11TBXA2RPIK3R1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed